A phase-II trial of STI-2099 (COVIDROPS) in COVID-19 patients
Latest Information Update: 21 Jan 2022
At a glance
- Drugs STI-2099 (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- Sponsors Sorrento Therapeutics
Most Recent Events
- 21 Jan 2022 New trial record
- 19 Jan 2022 According to a Sorrento Therapeutics media release, the company has planned Phase 2 trials in Mexico which enrolls children as well as adults.